Your missing guide to breakthrough biotech
This is Decoding Bio. A community of writers, scientists, founders, and funders focused on exploring the boundaries of bio, and elevating an understanding of cutting edge developments in what the kids are calling biotech.
We started Decoding Bio to fill a gap in content and start some conversation around biotech. Exciting new technology like AI is being rapidly deployed across every aspect of biology. We felt there ought to be a place to host thoughtful content and discussion. That's this. This is that.
Meet the team
We’re friends that happen to also be engineers, scientists, doctors, inventors, and investors. We’re building this community to share what we think really matters—and we want you to be a part of it.
Pablo Lubroth: neuropharmacology and biochem eng. GP at Interlagos. Spotify playlist hoarder.
Amee Kapadia: biomedical engineer by training, now VC at Cantos. Professional Costco shopper.
Zahra Khwaja: math and bio @ Cambridge & Harvard. Strategy and BD @ Charm Therapeutics. Abstract minimal psy trance - always.
Thomas Vanderstichele: genomics PhD @ Sanger & Biochem @ Oxford. History lover.
Mikaela Kimpton: strategy & ops @ HSBC Innovation Banking. National Parks nerd.
Matthew Nemeth: ml for therapeutic proteins, PhD @ Columbia. Water polo evangelist.
What to expect
Our mission is simple. We translate technical developments and trends into an easy-to-read format. We explore the boundaries of bio, and help you understand the cutting edge developments. We cut through the hype, but also imagine the possibilities and consequences of what these novel technologies could do. If you’re bio-curious, join us. There’s never been a more exciting time, or a more exciting field.
At Decoding Bio you will find:
1. BioByte: our Substack newsletter
Each week we highlight notable news—from the latest scientific papers to the latest funding rounds—and everything in between. All in one place.
2. Our Events
We’re getting together in-person to decode together. If you’re bio-curious, you’re welcome. We host an annual invite-only AI x Bio Summit at the NYSE. Subscribe for more details.
3. Reports
An encapsulated snapshot of recent technological developments, intriguing companies, and scientific breakthroughs - curated from our community.
We’re read by some of the biggest names in bio x tech
50,000+ monthly views / 11,000+ subscribers including:
Leaders at Amazon, Google, NVIDIA, Amgen, Genentech, AstraZeneca, Lilly, BCG, McKinsey, Microsoft, Novartis, Novo Nordisk, Recursion, Sanofi, Schrodinger
Partners at a16z, 8VC, DCVC, Flagship Pioneering, General Atlantic, General Catalyst, Dimension Capital, Lux, NFX, Curie Bio, True Ventures
Researchers (including at least one Nobel Laureate!) at the Arc Institute, American Cancer Society, Francis Crick Institute, Gladstone Institute, Wyss Institute, Stanford, Harvard, Yale, Columbia, MIT, Princeton, Cornell, Caltech, NYU, Berkeley, Brown, Dartmouth, UChicago, UPenn
Editors at Endpoints News, the Wall Street Journal, Stat News
We’d love to hear from you.
We’re always on the look out for tips on new companies, events, and advancements in the bio space. If you’re part of a startup, in academia, or just bio-curious, we’d love to hear from you. Send us a message or reach out to us individually via our About page. Our DMs are open.
